Hyperthermic Intraperitoneal Chemotherapy clinical trials

Explore recruiting hyperthermic intraperitoneal chemotherapy clinical trials.

Recruiting hyperthermic intraperitoneal chemotherapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hyperthermic Intraperitoneal Chemotherapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ALBU-CHIP - Efficacy of human 20% albumin solution + Ringer Lactate versus Ringer Lactate for fluid replacement strategy during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy : a randomized clinical trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

CHIPOR : Randomized phase III study evaluating hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

COLOVERT – Conversion therapy in colorectal cancer with peritoneal metastases not amenable to upfront cytoreductive surgery and HIPEC: a phase II “pick-the-winner” open-label randomized trial

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; PERISCOPE-2

Sweden, Finland, Denmark, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Decrease of intraoperative fluid administration in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) with vasopressin (HiPRESS)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

EFFIPEC – Efficacy of Hyperthermic Intraperitoneal Chemotherapy Single-arm Phase I study, followed by an open-label, randomized, controlled registry-based phase III trial

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hyperthermic Intraperitoneal Chemotherapy trials by city

Hyperthermic Intraperitoneal Chemotherapy in Toronto Hyperthermic Intraperitoneal Chemotherapy in Vancouver Hyperthermic Intraperitoneal Chemotherapy in Montreal Hyperthermic Intraperitoneal Chemotherapy in Calgary Hyperthermic Intraperitoneal Chemotherapy in Edmonton Hyperthermic Intraperitoneal Chemotherapy in Ottawa Hyperthermic Intraperitoneal Chemotherapy in Winnipeg Hyperthermic Intraperitoneal Chemotherapy in Quebec City Hyperthermic Intraperitoneal Chemotherapy in Hamilton Hyperthermic Intraperitoneal Chemotherapy in Kitchener Hyperthermic Intraperitoneal Chemotherapy in London Hyperthermic Intraperitoneal Chemotherapy in Halifax Hyperthermic Intraperitoneal Chemotherapy in New York Hyperthermic Intraperitoneal Chemotherapy in Los Angeles Hyperthermic Intraperitoneal Chemotherapy in Chicago Hyperthermic Intraperitoneal Chemotherapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease